arrow
D

D. Franchi

European Institute of Oncology IRCCS
H指数:35
被引数:4,348

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of ultrasound with computed tomography and whole-body diffusion-weighted MRI in prediction of surgical outcome using ESMO-ESGO criteria in patients with tubo-ovarian carcinoma: prospective ISAAC study

比较超声与计算机断层扫描和全身扩散加权MRI在预测输卵管卵巢癌患者手术结局中的应用:前瞻性ISAAC研究(采用ESMO-ESGO标准)

2025-11-040
OAAI
Quality of life and satisfaction with ospemifene for treating vulvovaginal atrophy in breast cancer survivors: six-month results from the PatiEnt satisfactiON studY (PEONY)

生活质量和对奥斯培米芬治疗乳腺癌幸存者外阴阴道萎缩的满意度:PEONY试验(PatiEnt satisfactiON studY)六个月结果

2025-08-070
PREAI
Ability Of Imaging Methods To Predict Surgical Outcome In Patients With Tubo-Ovarian Carcinoma Using ESMO-ESGO Criteria: A Prospective ISAAC Study

利用ESMO-ESGO标准评估影像学方法预测输卵管卵巢癌患者手术疗效的能力:一项前瞻性ISAAC研究

2025-02-010
PRE
Sonographic, Demographic, and Clinical Characteristics of Pre- and Postmenopausal Women with Endometrial Cancer; Results from a Post Hoc Analysis of the IETA4 (International Endometrial Tumor Analysis) Multicenter Cohort

绝经前和绝经后子宫内膜癌妇女的超声,人口统计学和临床特征; IETA4 (国际子宫内膜癌分析) 多中心队列的事后分析结果

2023-12-191
OAAI
Prediction of outcome in endometrial cancer improved by combining traditional with sonographic and demographic parameters: IETA4 cohort follow-up
2023-10-021
OAAI
Patient satisfaction with ultrasound, CT and WB-DWI/MRI for preoperative ovarian cancer staging: a multicentre prospective survey
2023-10-021
OAAI
Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort
2023-01-1220
OAAI
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers (September, 10.1245/s10434-022-12353-y, 2022)
2022-09-211
OAAI
ASO Visual Abstract: Clinical and Histopathologic Predictors Signaling Recurrence of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
2022-09-150
PRE